Severe hyperkalemia during cardiopulmonary bypass

Etiology and effective therapy

David P. Martin, Daniel Gomez, Joseph D. Tobias, William Schechter, Carlos Cusi, Robert E. Michler

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Hyperkalemia is considered a medical emergency as it can result in severe disturbances in cardiac rhythm and death. Although many causes of hyperkalemia exist, exogenous red blood cell transfusions are being recognized as the primary perioperative etiology. The authors report a case of severe intraoperative hyperkalemia associated with the use of allogeneic blood products (packed red blood cells), during a surgical mission to a developing country. The patient was undergoing repeat mitral valve replacement with cardiopulmonary bypass (CPB) and developed significant hyperkalemia with a serum potassium value of 9.9 mEq/L. Successful intraoperative therapies were instituted with a gradual reduction in the serum potassium value to 4.8 mEq, which allowed the patient to be weaned from CPB. The authors review the etiology of hyperkalemia in children including its relationship with allogeneic red blood cell transfusions and treatment modalities including specific therapies which can be instituted during CPB.

Original languageEnglish (US)
Pages (from-to)197-200
Number of pages4
JournalWorld Journal for Pediatric and Congenital Hearth Surgery
Volume4
Issue number2
DOIs
StatePublished - 2013

Fingerprint

Hyperkalemia
Cardiopulmonary Bypass
Erythrocyte Transfusion
Potassium
Therapeutics
Serum
Mitral Valve
Developing Countries
Emergencies
Erythrocytes

ASJC Scopus subject areas

  • Surgery
  • Cardiology and Cardiovascular Medicine
  • Pediatrics, Perinatology, and Child Health

Cite this

Severe hyperkalemia during cardiopulmonary bypass : Etiology and effective therapy. / Martin, David P.; Gomez, Daniel; Tobias, Joseph D.; Schechter, William; Cusi, Carlos; Michler, Robert E.

In: World Journal for Pediatric and Congenital Hearth Surgery, Vol. 4, No. 2, 2013, p. 197-200.

Research output: Contribution to journalArticle

Martin, David P. ; Gomez, Daniel ; Tobias, Joseph D. ; Schechter, William ; Cusi, Carlos ; Michler, Robert E. / Severe hyperkalemia during cardiopulmonary bypass : Etiology and effective therapy. In: World Journal for Pediatric and Congenital Hearth Surgery. 2013 ; Vol. 4, No. 2. pp. 197-200.
@article{bcd11e30febc439792a42e57ddb85155,
title = "Severe hyperkalemia during cardiopulmonary bypass: Etiology and effective therapy",
abstract = "Hyperkalemia is considered a medical emergency as it can result in severe disturbances in cardiac rhythm and death. Although many causes of hyperkalemia exist, exogenous red blood cell transfusions are being recognized as the primary perioperative etiology. The authors report a case of severe intraoperative hyperkalemia associated with the use of allogeneic blood products (packed red blood cells), during a surgical mission to a developing country. The patient was undergoing repeat mitral valve replacement with cardiopulmonary bypass (CPB) and developed significant hyperkalemia with a serum potassium value of 9.9 mEq/L. Successful intraoperative therapies were instituted with a gradual reduction in the serum potassium value to 4.8 mEq, which allowed the patient to be weaned from CPB. The authors review the etiology of hyperkalemia in children including its relationship with allogeneic red blood cell transfusions and treatment modalities including specific therapies which can be instituted during CPB.",
author = "Martin, {David P.} and Daniel Gomez and Tobias, {Joseph D.} and William Schechter and Carlos Cusi and Michler, {Robert E.}",
year = "2013",
doi = "10.1177/2150135112467213",
language = "English (US)",
volume = "4",
pages = "197--200",
journal = "World journal for pediatric & congenital heart surgery",
issn = "2150-1351",
publisher = "Sage Periodicals Press",
number = "2",

}

TY - JOUR

T1 - Severe hyperkalemia during cardiopulmonary bypass

T2 - Etiology and effective therapy

AU - Martin, David P.

AU - Gomez, Daniel

AU - Tobias, Joseph D.

AU - Schechter, William

AU - Cusi, Carlos

AU - Michler, Robert E.

PY - 2013

Y1 - 2013

N2 - Hyperkalemia is considered a medical emergency as it can result in severe disturbances in cardiac rhythm and death. Although many causes of hyperkalemia exist, exogenous red blood cell transfusions are being recognized as the primary perioperative etiology. The authors report a case of severe intraoperative hyperkalemia associated with the use of allogeneic blood products (packed red blood cells), during a surgical mission to a developing country. The patient was undergoing repeat mitral valve replacement with cardiopulmonary bypass (CPB) and developed significant hyperkalemia with a serum potassium value of 9.9 mEq/L. Successful intraoperative therapies were instituted with a gradual reduction in the serum potassium value to 4.8 mEq, which allowed the patient to be weaned from CPB. The authors review the etiology of hyperkalemia in children including its relationship with allogeneic red blood cell transfusions and treatment modalities including specific therapies which can be instituted during CPB.

AB - Hyperkalemia is considered a medical emergency as it can result in severe disturbances in cardiac rhythm and death. Although many causes of hyperkalemia exist, exogenous red blood cell transfusions are being recognized as the primary perioperative etiology. The authors report a case of severe intraoperative hyperkalemia associated with the use of allogeneic blood products (packed red blood cells), during a surgical mission to a developing country. The patient was undergoing repeat mitral valve replacement with cardiopulmonary bypass (CPB) and developed significant hyperkalemia with a serum potassium value of 9.9 mEq/L. Successful intraoperative therapies were instituted with a gradual reduction in the serum potassium value to 4.8 mEq, which allowed the patient to be weaned from CPB. The authors review the etiology of hyperkalemia in children including its relationship with allogeneic red blood cell transfusions and treatment modalities including specific therapies which can be instituted during CPB.

UR - http://www.scopus.com/inward/record.url?scp=84908233888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908233888&partnerID=8YFLogxK

U2 - 10.1177/2150135112467213

DO - 10.1177/2150135112467213

M3 - Article

VL - 4

SP - 197

EP - 200

JO - World journal for pediatric & congenital heart surgery

JF - World journal for pediatric & congenital heart surgery

SN - 2150-1351

IS - 2

ER -